Osteoarthritis Trial, Recruiting (NCT04210284)

Osteoarthritis Trial, Recruiting NCT04210284 Sponsor: NYU Langone Health Condition: Osteoarthritis

Printed from Voxsanity (voxsanity.com.au) — NCT04210284 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Osteoarthritis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are scheduled for a planned (non-urgent) first-time total hip or total knee replacement surgery
People who are aged between 55 and 95 years old
People whose blood test results show signs of malnutrition, meaning at least one of the following: a serum albumin level of 3.5 mg/dl or below, a pre-albumin level below 15 mg/dl, or a transferrin level below 200 mg/dl

Who may not be able to join:

People with a past history of a joint infection (septic arthritis) in the affected joint
People who have a known allergy to oral nutritional supplements
People who are unable to take or swallow oral nutritional supplements
People who have a condition that prevents their body from properly absorbing protein
People who have or have had an eating disorder
People with advanced kidney or liver disease
People who are having revision surgery (a repeat or corrective joint replacement), emergency surgery, a partial hip replacement (hemiarthroplasty), or a partial knee replacement (unicompartmental knee arthroplasty)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ran Schwarzkopf, NYU Langone

Phone: 212-598-6245

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04210284

Sponsor: NYU Langone Health

Phase: Not Applicable

Status: Recruiting

Condition: Osteoarthritis

Trial contact: 212-598-6245

More information: https://clinicaltrials.gov/study/NCT04210284

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are scheduled for a planned (non-urgent) first-time total hip or total knee replacement surgery
People who are aged between 55 and 95 years old
People whose blood test results show signs of malnutrition, meaning at least one of the following: a serum albumin level of 3.5 mg/dl or below, a pre-albumin level below 15 mg/dl, or a transferrin level below 200 mg/dl

Who may not be able to join:

People with a past history of a joint infection (septic arthritis) in the affected joint
People who have a known allergy to oral nutritional supplements
People who are unable to take or swallow oral nutritional supplements
People who have a condition that prevents their body from properly absorbing protein
People who have or have had an eating disorder
People with advanced kidney or liver disease
People who are having revision surgery (a repeat or corrective joint replacement), emergency surgery, a partial hip replacement (hemiarthroplasty), or a partial knee replacement (unicompartmental knee arthroplasty)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

NYU Langone Health

Registry

ClinicalTrials.gov

Start date

6 July 2021

Est. completion

31 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in the patients' albumin, pre-albumin, and/or transferrin levels

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov